GenV is a prospective, whole-of-state, cross-generational study in Victoria (population 6.7 million, 18% of whom are 0–14 year-old children), Australia, targeting all the expected 150,000 newborns and their parents over two full years from late 2021. Since GenV targets an entire population, it covers all service sectors, geographies, morbidities, and socioeconomic and demographic groups. Although relatively affluent, the full range of advantage-disadvantage exists; Victoria’s multiple ethnicities speak more than 250 languages, around 1% identify as Aboriginal and/or Torres Strait Islander, and over 70% of parents report that their child has at least 1 ongoing health or developmental problem at every age from 2 to 15 years.
Study design
Cohort - primary caregiver and child, Biobank, Registry, Cohort - intergenerational
Number of participants at first data collection
> 120,000 (participants as of 2024)
Recruitment is ongoing
Age at first data collection
Birth (children)
Varied (mothers)
Participant year of birth
2021 - 2023 (children)
Varied (mothers)
Participant sex
All
Representative sample at baseline?
Metropolitan, regional, and rural communities of Victoria, Australia.
Sample features
Country
Year of first data collection
2011
Primary Institutions
Murdoch Children’s Research Institute (MCRI)
University of Melbourne
Profile paper DOI
Funders
Paul Ramsay Foundation
The Royal Children’s Hospital Foundation (RCHF)
Victorian Government
Ongoing?
Yes
Data types collected
Engagement
Keywords